IONS
Ionis Pharmaceuticals Inc
45.60$
+2.4%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +236.1% | -630.7% | – | +246.2% | -42.7% | -89.6% | -14.2% | -990.8% | – | – | – | |
| – | +8.9% | -11.8% | -7.6% | +50.1% | +27.7% | +7.3% | +14.0% | +13.0% | +1.8% | -12.6% | +15.5% | |
| – | +89.0% | +21.6% | +19.2% | +52.7% | +11.6% | +57.0% | -47.6% | -16.9% | +5.5% | +23.1% | +2.8% | |
| – | +775.8% | +28.1% | +9.7% | -285.2% | – | +227.7% | -75.2% | -21.3% | – | – | – | |
| – | +294.7% | -836.6% | – | +1,046.6% | -133.8% | – | – | – | -1,120.5% | – | – | |
| – | +5.8% | -1.9% | +228.4% | -53.4% | +105.5% | +13.1% | -56.4% | +12.3% | +39.4% | +61.7% | +13.6% | |
| – | -27.5% | – | -733.0% | +159.4% | -95.6% | – | -29.0% | -234.8% | -18.5% | -37.4% | +107.3% | |
| – | – | – | – | – | – | – | – | -34.5% | – | – | – | |
| – | +7.9% | -49.4% | +1,908.6% | +88.0% | -107.2% | +163.3% | -81.5% | -34.5% | – | – | – | |
| – | -101.6% | +449.5% | – | +72.7% | -122.8% | – | +33.4% | -112.1% | – | -151.4% | – | |
| – | -58.5% | -53.9% | +1,910.6% | +107.7% | -79.0% | -696.5% | – | -122.5% | – | -25.8% | +41.4% | |
| – | – | – | – | +231.9% | +171.1% | -170.6% | – | -225.7% | – | -228.0% | – | |
| – | – | -1,418.5% | – | +329.4% | -47.1% | -101.7% | – | -2,383.1% | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.